Therapeutic Applications (cancer therapy, targeted drug delivery)
Start with the big picture
The lesson surveys several therapeutic strategies. Gadolinium isotopes can capture neutrons and produce electrons that damage tumor-cell DNA locally, while beta-emitting agents such as lutetium-177 compounds, samarium-153, and holmium-166 microspheres are used in specific treatment contexts described in the source. Other approaches include brachytherapy seeds, lanthanoid-doped radiosensitizers, and upconversion nanoparticles that support photodynamic therapy or image-guided release. For targeted delivery, chelates can link therapeutic or imaging ions to peptides or antibodies, while polymers, dendrimers, and liposomes can serve as drug carriers. Luminescent europium and terbium also offer a way to follow carrier distribution. Together, these examples show how lanthanoid chemistry can combine targeting, treatment, imaging, and delivery.
What you'll learn
- Explain how lanthanoid properties support therapeutic and imaging applications.
- Differentiate neutron-capture therapy from beta-emitter radiopharmaceutical approaches.
- Describe how chelates and nanoscale carriers can support targeted drug delivery.
- Summarize the roles of upconversion, radiosensitization, and luminescent tracking.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.